August 2013 - IOZK

TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro

2013-08-19/in International Publications, Newcastle Disease Virus /von 2013-08-19 / Anat Rec (Hoboken) 2013 Oct;296(10):1552-60

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

2013-08-14/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48

Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer

2013-08-13/in Dendritic Cells, International Publications, NSCLC /von 2013-08-13 / Cryobiology 2013 Oct;67(2):235-40

In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

2013-08-03/in Cervical Cancer, Dendritic Cells, International Publications /von 2013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-62

Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer

2013-08-01/in Dendritic Cells, Hyperthermia, International Publications /von 2013-08-01 / Immunology 2013 Aug;139(4):407-15

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium

2013-08-01/in Breast Cancer, Dendritic Cells, International Publications /von 2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9

Current status and future perspectives of dendritic cell-based cancer immunotherapy

2013-08-01/in Dendritic Cells, International Publications /von 2013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-71